The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide

Απλή σελίδα τεκμηρίου
dc.contributor.authorNikas, S.en
dc.contributor.authorRizos, E.en
dc.contributor.authorMilionis, H.en
dc.contributor.authorBairaktari, E.en
dc.contributor.authorKalaitzidis, R.en
dc.contributor.authorSiamopoulos, K.en
dc.contributor.authorElisaf, M. S.en
dc.date.accessioned2015-11-24T19:41:36Z
dc.date.available2015-11-24T19:41:36Z
dc.identifier.issn1470-3203-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/24510
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAntihypertensive Agents/adverse effects/*therapeutic useen
dc.subjectBlood Pressure/drug effectsen
dc.subjectDrug Therapy, Combinationen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectHypertension/*drug therapy/*metabolism/physiopathologyen
dc.subjectIndapamide/adverse effects/*therapeutic useen
dc.subjectLosartan/*therapeutic useen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectUric Acid/antagonists & inhibitors/blood/*metabolismen
dc.titleThe effects of the addition of losartan on uric acid metabolism in patients receiving indapamideen
heal.abstractOBJECTIVE: A number of adverse metabolic effects are associated with indapamide administration, including an increase in serum uric acid levels. It has been reported that losartan can significantly decrease serum uric acid levels. However, there are no data on the effects of combination therapy of losartan with indapamide on uric acid metabolism. METHODS: We studied 20 hypertensive patients in whom serum metabolic parameters, including uric acid levels in serum and urine, were studied before and after eight weeks of indapamide administration (2.5 mg once daily) as well as eight weeks after combination treatment with indapamide (2.5 mg once daily)and losartan (50 mg/day). RESULTS: Indapamide evoked a significant decrease in systolic and diastolic blood pressure from a mean value of 157 +/- 12 mmHg/96 +/- 10 mmHg to a mean value of 139 +/- 14 mmHg/92 +/- 5 mmHg (p<0.01 for both comparisons). However, a significant increase in serum uric acid levels was noticed after indapamide administration (from a mean value of 4.9 +/- 1.6 mg/dl to a mean value of 5.9 +/- 1.2 mg/dl, p<0.01), associated with a decrease in the fractional excretion of uric acid(from a mean value of 9 +/- 5% to a mean value of 7 +/- 5.5%, p<0.05). The addition of losartan caused a further decrease in blood pressure from a mean value of 139 +/- 14 mmHg/92 +/- 5 mmHg to a mean value of 120 +/- 15 mmHg/84 +/- 4 mmHg (p<0.01 for both comparisons). This was followed by a significant decrease in serum uric acid levels to 5 +/- 1.1 mg/dl(p<0.01) due to a substantial increase in fractional urate excretion (from 7 +/- 5.5 to 8.7 +/- 6%, p<0.05). CONCLUSION: The addition of losartan could offset the hyperuricaemic effect of indapamide administration.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.3317/jraas.2000.045-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/11881040-
heal.identifier.secondaryhttp://jra.sagepub.com/content/1/3/289.full.pdf-
heal.journalNameJ Renin Angiotensin Aldosterone Systen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2000-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Πρωτότυπος φάκελος/πακέτο

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
Nikas-2000-The effects of the a.pdf
Μέγεθος:
220.06 KB
Μορφότυπο:
Adobe Portable Document Format
Κατεβάστε

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ